（来源：中国经济导报） 樟树药业有1800多年的历史，具有深厚的中医药文化底蕴，享有"药不到樟树不齐，药不过樟树不灵"的 盛誉。医药产业是樟树的首位产业和支柱产业，经过长期发展，樟树医药产业已形成药地、药企、药 市、药会齐头并进，生产、加工、销售、科研一体化的产业发展格局。近年来，江西省樟树市积极践行 中医药强省战略，围绕"中国药都"振兴主线，以项目为重，以发展为要，全力提升中医药产业竞争力， 全市中医药产业发展亮点纷呈。 中药材种植实现规模化标准化发展。据统计，目前樟树市中药材种植面积超50万亩，主要种植品种为樟 树道地药材"三子一壳一皮一草"（黄栀子、车前子、吴萸子、枳壳、樟头红陈皮、九牛草），有国家地 理标志保护产品3个（樟树吴茱萸、樟树黄栀子、清江枳壳），樟树车前子、樟头红陈皮正在申报过程 中。目前，全市24家企业被核准使用"清江枳壳"地理标志专用标志，16家企业被核准使用"樟树黄栀 子"地理标志专用标志。由樟树市主导制定的江西省首个中药材产品国际标准《中药材-栀子》发布，枳 壳国际标准也已通过NP（新工作项目提案）现场投票，成功立项。双金园艺场被评为省级农业产业融 合发展示范园，建成全国首个中药气象 ...

Group 1 - The stock price of Renhe Pharmaceutical (000650) closed at 6.26 yuan on November 6, 2025, with no change in price, a turnover rate of 0.98%, a trading volume of 130,100 shares, and a transaction amount of 81.26 million yuan [1] - The company's classic formula, Er Dong Tang granules, did not participate in this year's medical insurance negotiations, as confirmed by the company secretary [2] - On November 6, there was a net outflow of 4.07 million yuan from main funds, indicating a cautious attitude from major investors [2] Group 2 - On the same day, there was a net inflow of 1.18 million yuan from speculative funds and a net inflow of 2.89 million yuan from retail investors [2]

Group 1: Technological Innovation in Jiangxi - Jiangxi is actively constructing a work system led by enterprises, guided by the government, and supported by universities and research institutions to overcome technological bottlenecks [1] - The province has launched six major actions to promote technological innovation, optimizing the innovation platform system and integrating technological and industrial innovation [1] - According to the "China Regional Science and Technology Innovation Evaluation Report 2025," Jiangxi's comprehensive science and technology innovation index is 69.63%, ranking 15th nationally [1] Group 2: Aviation Industry Development - The eVTOL (electric vertical takeoff and landing) sector has become a popular area for innovation, with Jiangxi leveraging its strong general aviation manufacturing foundation to upgrade its aviation industry [2] - A cooperation agreement was signed in May 2024 to address bottlenecks in eVTOL development, focusing on key technologies such as aerodynamic design and high-performance electric propulsion systems [3] - The successful first flight of the AR-E3000 eVTOL prototype in July 2024 demonstrates Jiangxi's advancements in the field, with the aircraft designed for urban transportation and emergency rescue in complex terrains [4] Group 3: Pharmaceutical Industry Transformation - Jiangxi's Renhe Group has transitioned from traditional to intelligent pharmaceutical manufacturing, utilizing smart equipment for the production of traditional Chinese medicine [5] - The company has developed a new granule formulation of the ancient prescription "Er Dong Tang," achieving a significant milestone in modernizing traditional medicine [6] - The successful production approval of "Er Dong Tang" granules marks a key development in Jiangxi's pharmaceutical industry, providing a model for high-quality development [6] Group 4: Swine Breeding Innovation - Research at Jiangxi Agricultural University has focused on genetic differences affecting pig growth and meat quality, leading to the development of the "Zhongxin No.1" breeding chip [7] - This chip allows for the analysis of over 56,000 genetic loci across 96 samples, facilitating the breeding of pigs with desirable traits [7] - The introduction of the "Shanxia Changhei" breed represents a breakthrough in local pig breeding, with over 15,000 breeding pigs sold across 12 provinces [8] Group 5: Major Technological Projects - The "2030 Pioneer Project" aims to address significant technological innovation needs in Jiangxi, planning to implement around 100 major projects by 2030 [8] - As of now, 17 major projects have been initiated, with 37 projects underway, some achieving preliminary results that are being transformed into industrial productivity [8] Group 6: Health Food Innovation - A research team from Nanchang University has developed a series of polysaccharide-based health foods using local medicinal resources, creating a new green manufacturing industry [9][10] - The project has received national recognition, with significant economic benefits reported from the commercialization of these health products [10] Group 7: Continuous Flow Technology in Pharmaceuticals - A team from Jiangxi Normal University has developed a continuous flow process for chemical synthesis, improving production efficiency and safety compared to traditional batch methods [11] - This technology has been applied in the production of various pharmaceuticals and agrochemicals, with total contract amounts reaching 138 million yuan [11]

Group 1: Agricultural Industry - The establishment of a 2,000-acre selenium-rich chili pepper industrial park in Gao'an has led to a significant increase in chili production, with a total planting area of 15,000 acres and a total output value exceeding 200 million yuan [3][2] - The introduction of green pest control technologies has reduced the use of chemical pesticides by 60% during the seedling stage, significantly improving product quality [3] - Jiangxi Shengnong Food Co., Ltd. has implemented automation and digital platforms across its entire production chain, enhancing efficiency and product quality [2][3] Group 2: Traditional Medicine and Innovation - The establishment of a traditional Chinese medicine industrial technology park by Renhe Group in Jiangxi has modernized ancient formulas into convenient granules, showcasing the integration of technology and traditional medicine [5] - The company has developed new products based on classic formulas, demonstrating the revitalization of traditional medicine through technological innovation [5] Group 3: Cultural Heritage and Innovation - Jinxi County has implemented a mechanism for the management of ancient buildings, allowing for financial support through "ancient village financial loans," revitalizing over 2,000 ancient structures [6] - The Tengwang Pavilion in Nanchang is undergoing urban renewal projects that enhance cultural exchange and improve visitor experiences, reflecting the city's international influence [7] - The Wengang Town's Chinese Brush Culture Museum promotes local brush-making workshops and enhances brand recognition through shared resources and a unified branding strategy [8]

Group 1: Company Performance - Western Gold achieved operating revenue of 7.001 billion yuan in 2024, a year-on-year increase of 56.68%, and net profit of 290 million yuan, turning from loss to profit [1] - Jihong Co. reported operating revenue of 5.529 billion yuan in 2024, a year-on-year decrease of 17.41%, with net profit down 47.28% to 182 million yuan [2] - Sanli Co. achieved operating revenue of 227 million yuan in 2024, a year-on-year increase of 14.35%, but reported a net loss of 49.88 million yuan, narrowing the loss by 56.50% [2] - Sanli Co. reported operating revenue of 2.590 billion yuan in 2024, a year-on-year increase of 25.25%, with net profit of 68.09 million yuan, up 59.07% [4] - Huaiqi Mountain achieved operating revenue of 1.631 billion yuan in 2024, a year-on-year increase of 15.60%, with net profit of 196 million yuan, up 17.74% [6] - Huayuan Holdings reported operating revenue of 2.449 billion yuan in 2024, a year-on-year increase of 1.60%, with net profit of 70.74 million yuan, up 739% [8] - Hangfa Power achieved operating revenue of 47.880 billion yuan in 2024, a year-on-year increase of 9.48%, but net profit decreased by 39.48% to 860 million yuan [10] - Zhongcai Energy reported operating revenue of 2.324 billion yuan in 2024, a year-on-year decrease of 24.21%, with net profit down 94.70% to 760,240 yuan [10] - Longxing Technology achieved operating revenue of 4.355 billion yuan in 2024, a year-on-year increase of 1.95%, with net profit of 142 million yuan, up 28.70% [11] - Jinying Co. reported operating revenue of 1.308 billion yuan in 2024, a year-on-year decrease of 4.52%, with net profit down 36.73% to 22.35 million yuan [12] - Zhujiang Co. achieved operating revenue of 1.558 billion yuan in 2024, a year-on-year decrease of 52.38%, but net profit turned to profit at 15.57 million yuan [12] - Chuanwang Media reported operating revenue of 288 million yuan in 2024, a year-on-year increase of 20.05%, but net profit decreased by 24.02% to 23.80 million yuan [13] - Ronglian Technology achieved operating revenue of 2.022 billion yuan in 2024, a year-on-year decrease of 14.91%, with net profit of 28.11 million yuan, up 107.87% [13] - Oufeiguang reported operating revenue of 20.437 billion yuan in 2024, a year-on-year increase of 21.19%, but net profit decreased by 24.09% to 58.38 million yuan [14] Group 2: Dividend Proposals - Western Gold proposed a cash dividend of 0.5 yuan per 10 shares [1] - Jihong Co. proposed a cash dividend of 1.58 yuan per 10 shares [2] - Sanli Co. proposed a cash dividend of 1.50 yuan per 10 shares [4] - Huaiqi Mountain proposed a cash dividend of 4.00 yuan per 10 shares [6] - Huayuan Holdings proposed a cash dividend of 1.00 yuan per 10 shares [8] - Hangfa Power proposed a cash dividend of 0.97 yuan per 10 shares [10] - Zhongcai Energy proposed a cash dividend of 0.05 yuan per 10 shares [10] - Longxing Technology proposed a cash dividend of 1.20 yuan per 10 shares [11] - Jinying Co. proposed a cash dividend of 1.00 yuan per 10 shares [12] - Zhujiang Co. proposed a cash dividend of 1.25 yuan per 10 shares [12] - Chuanwang Media proposed a cash dividend of 1.25 yuan per 10 shares [13] - Ronglian Technology proposed a cash dividend of 0.0425 yuan per share [13] - Oufeiguang proposed a cash dividend of 0.0178 yuan per share [14]